Sigrid Behr, PhD

Novartis Pharma AG
Basel, Switzerland

Disclosure information not submitted.

Presentation(s):

• Estimating the Prevalence of Immunoglobulin A Nephropathy (IgAN) in the European Union: A Weighted Average Estimation Approach Utilizing Diagnostic Procedure Frequency in a Rare Disease Setting

  Monday, August 26, 2024
  6:00 PM – 6:05 PM CEST